Access to health for persons with disabilities

with Duchenne muscular dystrophy, and it has increased life expectancy from approximately 14 years to upwards of 25 years.[30] While evidence-based interventions are generally to be welcomed, there can be concerns about other pioneering treatments for which efficacy may be uncertain, and ethical problems might arise, particularly regarding lack ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download